2011Journal of Clinical Pulmonary MedicineRequires access

Combined assays of tumor marker VEGF、CEA、CA153 for differential diagnosis of pleural effusion

Zhang Zheng-sho

Open publisher page 0 citations

Abstract

Objective To study the clinical significance of tumormarkers combined assay in the differential diagnosis of pleural effusion.Methods80 hydrothorax samples were collected from 80 in-patients with pleural effusion.Among them,50 patients were suffered with malignant pleural effusion and 30 patients with benign pleural effusion.The concentration of VEGF 、CEA、and CA153 was determined by ELISA and chemiluminescence.ResultsVEGF、CEA、and CA153 in malignant group were significantly higher than that in benign pleura effusion group(P0.01).The sensitivity of combined assay with hydrothorax VEGF、CEA and CA153 in diagnosing malignant pleural effusion was proved.Conclusion Tumormarkers of VEGF、CEA、and CA153 have high clinical values in the differential diagnosis of pleural effusion.The combined assaywith VEGF+CEA is recommended.

About this research paper

What this paper is about

Objective To study the clinical significance of tumormarkers combined assay in the differential diagnosis of pleural effusion.Methods80 hydrothorax samples were collected from 80 in-patients with pleural effusion.Among them,50 patients were suffered with malignant pleural effusion and 30 patients with benign pleural effusion.The concentration of VEGF 、CEA、and CA153 was determined by ELISA and chemiluminescence.ResultsVEGF、CEA、and CA153 in malignant group were significantly higher than that in benign pleura effusion group(P0.01).The sensitivity of combined assay with hydrothorax VEGF、CEA and CA153 in diagnosing malignant pleural effusion was proved.Conclusion Tumormarkers of VEGF、CEA、and CA153 have high clinical values in the differential diagnosis of pleural effusion.The combined assaywith VEGF+CEA is recommended.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the clinical significance of tumormarkers combined assay in the differential diagnosis of pleural effusion.Methods80 hydrothorax samples were collected from 80 in-patients with pleural effusion.Among them,50 patients were suffered with malignant pleural effusion and 30 patients with benign pleural effusion.The concentration of VEGF 、CEA、and CA153 was determined by ELISA and chemiluminescence.ResultsVEGF、CEA、and CA153 in malignant group were significantly higher than that in benign pleura effusion group(P0.01).The sensitivity of combined assay with hydrothorax VEGF、CEA and CA153 in diagnosing malignant pleural effusion was proved.Conclusion Tumormarkers of VEGF、CEA、and CA153 have high clinical values in the differential diagnosis of pleural effusion.The combined assaywith VEGF+CEA is recommended.

Key concepts: Medicine, Malignant pleural effusion, Pleural effusion, Differential diagnosis, Hydrothorax, Effusion, Pathology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Combined assays of tumor marker VEGF、CEA、CA153 for differential diagnosis of pleural effusion — Research Paper | ScholarLens